JPMorgan analyst Eric Joseph downgraded CAMP4 Therapeutics Corp (NASDAQ: CAMP) from Overweight to Neutral.The analyst comments: "We certainly acknowledge that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE